Tumors can exhibit selective allelic losses of HLA
class I antigens as part of altered HLA phenotypes. In
colorectal tumors, the HLA class I allele most frequently lost is
HLA-B44, although the precise mechanism responsible for this loss has not been described to date. From a total of 95 colorectal cryopreserved
tumor samples, we selected (by immunohistochemical staining) 13
tumors with HLA-B44-negative expression. Loss of heterozygosity at 6p21.3 was demonstrated to be the cause of the negative expression in 4 cases. In the remaining 9 cases, structural analyses of microdissected tissue samples of the 3 subtypes of
HLA-B44 loss in these
tumors (B*4402, B*4403 and B*4405) did not reveal any mutations. However, all 3 subtypes of
HLA-B44 presented in this study shared a common characteristic: the presence of an aspartic
amino acid residue at position 114 in the HLA class I heavy chain. This residue has been described as determining
tapasin dependence for the surface expression of these alleles and therefore for antigen presentation. We studied
tapasin transcription by RT-PCR in these
tumors and found
tapasin downregulation in all 9
tumors samples with the HLA-B44-negative phenotype. In contrast,
tapasin was normally transcribed in HLA-B44-positive
colorectal tumors samples, as well as in 3 HLA-B44-negative laryngeal
carcinomas and 1
bladder tumor. Defective
tapasin transcription seems to be an alteration responsible for the absence of
HLA-B44 expression in
colorectal tumors, thus contributing to the generation of tumor immune escape phenotypes.